Middle cerebral artery territory infarction in a COVID-19 patient: a case report

  • Rizaldy Pinzon Duta Wacana Christian University School of Medicine, Yogyakarta, Indonesia; Bethesda Hospital, Yogyakarta, Indonesia
  • Vincent Ongko Wijaya Duta Wacana Christian University School of Medicine, Yogyakarta, Indonesia; Bethesda Hospital, Yogyakarta, Indonesia https://orcid.org/0000-0001-7147-851X
  • Dessy Paramitha Duta Wacana Christian University School of Medicine, Yogyakarta, Indonesia; Bethesda Hospital, Yogyakarta, Indonesia https://orcid.org/0000-0003-1738-3442
DOI: https://doi.org/10.13181/mji.cr.204707
Keywords: case reports, COVID-19, ischemic stroke, middle cerebral artery
Abstract viewed: 1129 times
PDF downloaded: 877 times
HTML downloaded: 207 times
EPUB downloaded: 130 times

Abstract

Coronavirus disease 2019 (COVID-19) mainly invades the respiratory system, yet previous reports have shown unusual manifestations of COVID-19, including cerebrovascular events. However, detailed case reports are still lacking. A 57-year-old male presented with sudden unconsciousness and right side lateralization for 6 hours before hospital admission. His test results were positive for severe acute respiratory syndrome coronavirus 2 infection. The head computed tomography (CT) scan showed infarction within the middle cerebral artery region. The scan was repeated 48 hours after admission and showed a massive infarct in the left hemisphere with hemorrhagic transformation. A chest CT showed the appearance of bronchopneumonia with ground-glass opacities in both lungs. The patient's condition was rapidly deteriorating, and he died on the third day after admission. Our findings suggest that ischemic vascular events may simultaneously develop due to the progression of COVID-19. A hypercoagulable state and vascular endothelial dysfunction have been proposed as complications of COVID-19 and are risk factors of thrombotic vascular events.

Author Biography

Rizaldy Pinzon, Duta Wacana Christian University School of Medicine, Yogyakarta, Indonesia; Bethesda Hospital, Yogyakarta, Indonesia

Department of Neurology, Head of Department

References

  1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13)1199-207. https://doi.org/10.1056/NEJMoa2001316

  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5

  3. Indonesian Task Force for COVID-19. Data of COVID-19 in Indonesia [Internet]. Indonesian Task Force for COVID-19; 2020 [cited 2020 Jul 14]. Available from: https://covid19.go.id/petasebaran.

  4. Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN. Neurologic characteristics in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Front Neurol. 2020;11:565. https://doi.org/10.3389/fneur.2020.00565

  5. Walcott BP, Miller JC, Kwon CS, Sheth SA, Hiller M, Cronin CA, et al. Outcomes in severe middle cerebral artery ischemic stroke. Neurocrit Care. 2014;21(1):20-6. https://doi.org/10.1007/s12028-013-9838-x

  6. Tunç A, Ünlübaş Y, Alemdar M, Akyüz E. Coexistence of COVID-19 and acute ischemic stroke report of four cases. J Clin Neurosci. 2020;77:227-9. https://doi.org/10.1016/j.jocn.2020.05.018

  7. Trejo Gabriel y Galán JM. Stroke as a complication and prognostic factor of COVID-19 [Ictus comocomplicación y como factor pronóstico de COVID-19] Neurología (English Edition). 2020;35(5):318-22. https://doi.org/10.1016/j.nrleng.2020.04.013

  8. Belani P, Schefflein J, Kihira S, Rigney B, Delman BN, Mahmoudi K, et al. COVID-19 is an independent risk factor for acute ischemic stroke. AJNR Am J Neuroradiol. 2020;41(8):1361-4. https://doi.org/10.3174/ajnr.A6650

  9. Zhai P, Ding Y, Li Y. The impact of COVID-19 on ischemic stroke: a case report. Infect Dis [Preprint]. 2020 [cited 2020 May 25]. A vailable from: h ttps://10.21203/rs.3.rs-20393/v1. https://doi.org/10.21203/rs.3.rs-20393/v1

  10. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of covid-19 in the young. N Eng J Med. 2020;382(60):e60. https://doi.org/10.1056/NEJMc2009787

  11. Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889-91. https://doi.org/10.1136/jnnp-2020-323586

  12. Zhang ZL, Hou YL, Li DT, Li FZ. Laboratory findings of COVID-19: a systematic review and meta-analysis. Scand J Clin Lab In vest. 2020;1-7. https://doi.org/10.1080/00365513.2020.1768587

  13. Reddy ST, Garg T, Shah C, Nascimento FA, Imran R, Kan P, et al. Cerebrovascular disease in patients with COVID-19: a review of the literature and case series. Case Rep Neurol. 2020;12(2):199-209. https://doi.org/10.1159/000508958

  14. Hartmann P, Schober A, Weber C. Chemokines and microRNAs in atherosclerosis. Cell Mol Life Sc. 2015;72(17):3253-66. https://doi.org/10.1007/s00018-015-1925-z

  15. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-tolymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage. J Transl Med. 2020;18:206. https://doi.org/10.1186/s12967-020-02374-0

  16. Wouters A, Nysten C, Thijs V, Lemmens R. Prediction of outcome in patients with acute ischemic stroke based on initial severity and improvement in the first 24 h. Front Neurol. 2018;9:308. https://doi.org/10.3389/fneur.2018.00308

  17. Zhang J, Yang Y, Sun H, Xing Y. Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann Transl Med. 2014;2(8):81. https://10.3978/j.issn.2305-5839.2014.08.08

  18. Tsivgoulis G, Katsanos AH, Ornello R, Sacco S. Ischemic stroke epidemiology during the COVID-19 pandemic: navigating uncharted waters with changing tides. Stroke. 2020;51(7):1924-6. https://doi.org/10.1161/STROKEAHA.120.030791

  19. Sweid A, Hammoud B, Bekelis K, Missios S, Tjoumakaris SI, Gooch MR, et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int J Stroke. 2020;1747493020937189. https://doi.org/10.1177/1747493020937189

  20. Yu B, Li X, Chen J, Ouyang M, Zhang H, Zhao X, et al. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J Thromb Thrombolysis. 2020;1-10. https://doi.org/10.1007/s11239-020-02171-y

  21. Zhao J, Li H, Kung D, Fisher M, Shen Y, Liu R. Impact of the COVID-19 epidemic on stroke care and potential solutions. Stroke. 2020;51:1996-2001. https://doi.org/10.1161/STROKEAHA.120.030225

Published
2020-11-14
How to Cite
1.
Pinzon R, Wijaya VO, Paramitha D. Middle cerebral artery territory infarction in a COVID-19 patient: a case report. Med J Indones [Internet]. 2020Nov.14 [cited 2024Apr.27];30(1):66–70. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/4707
Issue
Vol. 30 No. 1 (2021): March
Section
Case Report/Series

Copyright (c) 2020 Rizaldy Pinzon, Vincent Ongko Wijaya, Dessy Paramitha

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.